Skip to content

The mission of the Spinal Muscular Atrophy Foundation is to accelerate the development of treatments for SMA.

Spinal Muscular Atrophy is the leading genetic cause of death in young children.

1 in 50 people are carriers of the disease.

Three FDA approved drugs are now available.

More clinical trials are underway.

Scroll To Top